Edition:
United States

Biotechnology & Medical Research

Page 1

Medivir strengthens its clinical pipeline by entering into agreement to acquire a portfolio of clinical stage oncology programs

Wednesday, 2 Nov 2016 04:51pm EDT

Medivir AB :Medivir strengthens its clinical pipeline by entering into agreement to acquire a portfolio of clinical stage oncology programs.

Verastem licenses duvelisib from infinity pharmaceuticals

Wednesday, 2 Nov 2016 06:45am EDT

Infinity Pharmaceuticals Inc - : Verastem licenses duvelisib from Infinity Pharmaceuticals . Verastem is obligated to pay to infinity up to $28 million in milestones . Infinity is entitled to receive two milestone payments, $6 million upon positive data from duo study . $22 million upon first regulatory approval inside or outside of u.s. .Verastem will also pay infinity tiered mid-to-high single-digit royalties on net sales.

Verastem licenses duvelisib from infinity pharmaceuticals

Wednesday, 2 Nov 2016 06:45am EDT

Infinity Pharmaceuticals Inc - : Verastem licenses duvelisib from Infinity Pharmaceuticals . Verastem is obligated to pay to infinity up to $28 million in milestones . Infinity is entitled to receive two milestone payments, $6 million upon positive data from duo study . $22 million upon first regulatory approval inside or outside of u.s. .Verastem will also pay infinity tiered mid-to-high single-digit royalties on net sales.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary